Biocryst Pharmaceuticals

This is an early-stage study to first test the safety of a new drug called BCX17725 in healthy volunteers. It will then test multiple doses in people with Netherton syndrome, a rare genetic skin condition, to see how the body handles the drug and if it helps reduce skin redness, …

This is an early-stage study to check if a new drug called avoralstat is safe when injected into the eye of people with diabetic macular edema (DME), a condition that causes vision loss. The study will enroll 9 adults with DME to receive a single injection at one of three dose le…